GBM generates an immunosuppressive environment through multiple mechanisms, including the programmed cell death protein 1 (PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), lymphocyte activating gene 3 (LAG-3) pathway (226). Here, CTLA4 is linked to glioblastoma.